It has been more than two-and-a-half years since the U.S. Food and Drug Administration (FDA) issued its final rule on the Unique Device Identification (UDI) system. So, come September 24, the third deadline will be reached, requiring the balance of Class II medical devices to be compliant with the UDI rule which includes submitting them to the FDA’s Global Unique Device Identification Database (GUDID).
With the first two phases already implemented, Vice President, Healthcare, at GS1 US, Greg Bylo, helps us understand the previous deadlines and what medical device manufacturers need to do to prepare for the third phase.
Latest from Today's Medical Developments
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
- The compact, complex capabilities of photochemical etching
- Moticont introduces compact, linear voice coil motor
- Manufacturing technology orders reach record high in December 2025
